文献速递脑血管病

多模态CT或MRI指导未知发病时间缺血性卒中静脉溶栓

Multimodal CT or MRI for IV thrombolysis in ischemic stroke with unknown time of onset.
PubMed 文献 · Neurology · 2020-10-21

本研究基于机构登记数据,比较多模态CT与MRI两种影像选择方案在扩展或未知时间窗缺血性卒中患者静脉溶栓中的操作时间、安全性和疗效差异。结果显示CT组门-针时间更短,而症状性颅内出血和90天良好预后无显著差异,提示两种影像选择均安全,CT可加快治疗。

要点

  • 多模态CT与MRI选择静脉溶栓在未知或扩展时间窗均安全。
  • CT组门-针时间中位数45分钟,显著短于MRI组的75分钟。
  • 症状性颅内出血和90天良好预后两组无显著差异。

核心结论

  • 在未知或扩展时间窗的缺血性卒中患者中,基于多模态CT或MRI选择静脉溶栓均安全。
  • 使用CT进行影像选择可缩短门-针时间。

研究设计与样本

  • 研究为基于机构登记数据的回顾性分析,纳入2011年1月至2019年5月期间接受静脉溶栓的扩展或未知时间窗缺血性卒中患者。

主要发现

  • CT组与MRI组基线临床数据(包括卒中严重程度和从最后正常时间至入院时间)相似。
  • CT组门-针时间中位数(四分位距)为45(37-62)分钟,MRI组为75(59-90)分钟,平均差异为-28分钟(95%CI -35至-21)。
  • 症状性颅内出血发生率CT组2例(2.0%),MRI组4例(4.8%),调整比值比(aOR)0.47(95%CI 0.08-2.83)。
  • 90天良好预后CT组25例(33.8%),MRI组33例(42.9%),aOR 0.95(95%CI 0.45-2.02)。

临床怎么用

  • 对于未知或扩展时间窗的缺血性卒中患者,可依据本中心条件选择多模态CT或MRI筛选静脉溶栓,两者安全性相似。
  • 若追求更快的门-针时间,可优先考虑多模态CT进行影像选择。

局限性

  • 研究为单中心回顾性登记分析,证据等级为Class IV。
  • 样本量有限,且非随机分组,可能存在选择偏倚。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To investigate differences in procedure times, safety, and efficacy outcomes comparing 2 different protocols to enable thrombolysis in the extended or unknown time window after stroke onset with either multimodal CT or MRI. METHODS: Patients with ischemic stroke in the extended or unknown time window who received IV thrombolysis between January 2011 and May 2019 were identified from an institutional registry. Imaging-based selection was done by multimodal CT or MRI according to institutional treatment algorithms. RESULTS: IV thrombolysis was performed in 100 patients (54.3%) based on multimodal CT imaging and in 84 patients (45.7%) based on MRI. Baseline clinical data, including stroke severity and time from last seen normal to hospital admission, were similar in patients with CT and MRI. Door-to-needle times were shorter in patients with CT-based selection (median [interquartile range] 45 [37-62] minutes vs 75 [59-90] minutes; mean difference [95% confidence interval (CI)] -28 minutes [-35 to -21]). No differences were detected regarding the incidence of symptomatic intracranial hemorrhage (2 [2.0%] vs 4 [4.8%]; adjusted odds ratio [aOR] [95% CI] 0.47 [0.08-2.83]) and favorable outcome at day 90 (25 [33.8%] vs 33 [42.9%]; aOR 0.95 [0.45-2.02]). CONCLUSION: IV thrombolysis in ischemic stroke in the unknown or extended time window appeared safe in CT- and MRI-selected patients, while the use of CT imaging led to faster door-to-needle times. CLASSIFICATION OF EVIDENCE: This study provides Class IV evidence that for patients with ischemic stroke in the extended or unknown time window, imaging-based selection for IV thrombolysis by multimodal CT compared to MRI led to shorter door-to-needle times.

来源:Neurology,查看原文。版权归原作者所有。

引用

  1. Macha K, Hoelter P, Siedler G, et al. Multimodal CT or MRI for IV thrombolysis in ischemic stroke with unknown time of onset. Neurology. 2020. PMID: 33087492. doi:10.1212/WNL.0000000000011059

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。